Cargando…
Prophylactic octreotide does not reduce the incidence of postoperative chylothorax following lobectomy: Results from a retrospective study
Chylothorax after lobectomy is common, lacking reliable preventive measures. Octreotide is widely used for treatment of chyle leakage, but its role in preventing chylothorax has not been estimated. The aim of this study was to evaluate whether prophylactic octreotide could reduce the incidence of po...
Autores principales: | Zhang, Chu, Zhang, Hui, Wu, Wenbin, Liu, Dong, Yang, Dunpeng, Zhang, Miao, Lu, Cuntao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708833/ https://www.ncbi.nlm.nih.gov/pubmed/31335742 http://dx.doi.org/10.1097/MD.0000000000016599 |
Ejemplares similares
-
Octreotide Infusion for the Treatment of Congenital Chylothorax
por: Kobeisy, Sumayyah Ahmed Nezar, et al.
Publicado: (2020) -
Effects of somatostatin/octreotide treatment in neonates with congenital chylothorax
por: Yin, Rong, et al.
Publicado: (2017) -
Low Dose of Octreotide Can be Helpful in the Management of Congenital Chylothorax
por: Afsharpaiman, Shahla, et al.
Publicado: (2015) -
Late-onset chylothorax during chemotherapy after lobectomy for lung cancer: A case report and review of the literature
por: Zhang, Chu, et al.
Publicado: (2019) -
Prophylactic octreotide for postoperative pancreatic fistula in patients with pancreatoduodenectomy: Risk-stratified analysis
por: Yoon, So Jeong, et al.
Publicado: (2022)